Skip to main content
. 2021 Jan 11;13(2):116–127. doi: 10.1177/1941738120964817

Table 5.

Neuromuscular electrical stimulation (NMES) treatment parameters utilized in each included article a

Frequency Duty Cycle, s (on/off) Ramp Time Intensity Pulse Duration Waveform/Current Electrode Size
Feil et al16
 G1 b 50 5/10 2 s/1 s down 300-400 μs G1 b : 10 × 20 cm,
3 × 18 cm,
10 × 7.5 cm,
7 × 14 cm
 G2 c 50 10/20 1.5 s/1 s down G2c: 4 × 70 mm
round
Fitzgerald et al17 75 10/50 2 s up MT N/A 2.5 kHz triangular alternating burst 6.98 × 12.7 cm
Lieber et al38 50 10/20 2 s up MT unadjusted d 250 μs Asymmetrical balanced
Sisk et al70 40 10/30 0.5 s up MT 300 μs Rectangular waveform 5 × 10 cm
Stevens-Lapsley et al76 50 15/45 3 s up MT 250 μs Symmetrical biphasic 7.6 × 12.7 cm
Wigerstad-Lossing et al82 30 6/10 2 s up MT (65-100 mA) 300 μs Rectangular asymmetrical balanced biphasic 4 × 10 cm
Williams et al83 50 15/50 3.5 s up MT N/A 2.5 kHz sinusoidal alternating
Yoshida et al84
 G1 f 100 10/20 MT e 1 ms Symmetrical biphasic 5 × 9 cm
 G2 g 100 Continuous Sensory-level 1 ms Symmetrical biphasic 5 × 9 cm

MT, maximal tolerance; N/A, not applicable.

a

“—” indicates information not provided.

b

Feil et al16: group 1 (G1): Kneehab NMES.

c

Feil et al16: group 2 (G2): Polystim NMES.

d

Required to produce visible muscle contraction.

e

Intensity level was set to maximum toleration during the first treatment setup. This level was then utilized throughout the treatment sessions.

f

Yoshida et al84: group 1 (G1): motor-level NMES.

g

Yoshida et al84: group 2 (G2): sensory-level NMES.